Get it on Google Play

PLI Scheme: For Drug Intermediates and APIs

PLI Scheme:

Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).

Indian pharmaceutical industry:

  • It is the 3rd largest in the world by volume.
  • It has high market presence in several advanced economies such as the US and EU. The industry is well known for its production of affordable medicines, particularly in the generics space.
  • However the country is significantly dependent on the import of basic raw materials, viz., Bulk Drugs that are used to produce medicines.

About the PLI scheme:

  • To make India a manufacturing hub, the government had initially announced the PLI scheme for mobile phones, pharma products, and medical equipment sectors.
  • Notified on April 1, 2020, as a part of the National Policy on Electronics.
  • It proposes a financial incentive to boost domestic manufacturing and attract large investments in the electronics value chain.
  • In November 2020, the Union Cabinet gave its approval to introduce the Production-Linked Incentive (PLI) Scheme in 10 more sectors for enhancing India’s manufacturing capabilities and exports (Atmanirbhar Bharat).
Get it on Google Play

Leave a Reply

Your email address will not be published. Required fields are marked *